TATEO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 172
EU - Europa 157
AS - Asia 111
AF - Africa 15
Totale 455
Nazione #
US - Stati Uniti d'America 172
SG - Singapore 62
IT - Italia 59
CN - Cina 27
SE - Svezia 16
DE - Germania 15
BG - Bulgaria 14
CH - Svizzera 12
GB - Regno Unito 10
IN - India 9
CI - Costa d'Avorio 8
FI - Finlandia 8
IE - Irlanda 8
NL - Olanda 7
ID - Indonesia 6
JO - Giordania 4
TG - Togo 4
NG - Nigeria 3
AT - Austria 2
MY - Malesia 2
RU - Federazione Russa 2
UA - Ucraina 2
JP - Giappone 1
MD - Moldavia 1
PL - Polonia 1
Totale 455
Città #
Singapore 59
Bologna 18
Santa Clara 18
Boardman 16
Chandler 16
Ashburn 14
Sofia 14
Bern 12
Milan 11
Turin 9
Abidjan 8
Dublin 8
Jakarta 6
New York 6
Princeton 6
Helsinki 5
Hyderabad 5
Southend 5
Amman 4
Lomé 4
Munich 4
Redmond 4
Rimini 4
Abeokuta 3
Cologne 3
Columbus 3
Houston 3
Lappeenranta 3
Seattle 3
Woodbridge 3
Amsterdam 2
Beijing 2
Berlin 2
Breda 2
Florence 2
Guangzhou 2
Legnano 2
Los Angeles 2
Moscow 2
Nanjing 2
San Diego 2
Seri Kembangan 2
Shanghai 2
Slough 2
Utrecht 2
Vienna 2
Wilmington 2
Cambridge 1
Chengdu 1
Chisinau 1
Enschede 1
Fairfield 1
Fuzhou 1
Hangzhou 1
Jinan 1
Leicester 1
Modena 1
Prescot 1
Qingdao 1
Shijiazhuang 1
Southwark 1
Taizhou 1
Tokyo 1
Warsaw 1
Wenzhou 1
Yueqing 1
Totale 330
Nome #
Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors 70
Hacking pancreatic cancer: Present and future of personalized medicine 62
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances 57
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 41
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis 40
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 32
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma 28
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics 27
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study 26
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 22
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 20
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study 18
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? 17
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours 17
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma 13
Totale 490
Categoria #
all - tutte 2.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.457


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 3 4 0 0 3
2021/202241 0 0 1 0 3 1 0 8 5 3 15 5
2022/2023124 6 8 8 7 9 6 3 4 20 6 26 21
2023/2024147 10 11 13 17 19 32 0 18 3 9 9 6
2024/2025168 27 39 30 40 32 0 0 0 0 0 0 0
Totale 490